Barclays »

Kyverna Therapeutics shares owned by Barclays

Quarter-by-quarter ownership of Kyverna Therapeutics shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Kyverna Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Kyverna Therapeutics held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kyverna Therapeutics by Barclays

Quarter filed Position value Share count Share price at filing
2024-03-31 $1.1M 43k 24.83

More positions owned by Barclays

Invesco Qqq Tr Fund (QQQ)
Microsoft Corp Opt Put Option (MSFT)
Ishares Tr Fund (IWM)
Apple Opt Call Option (AAPL)
SPDR S&ampP 500 ETF TR Fund (SPY)
Nvidia Corporation Opt Call Option (NVDA)
Amazon (AMZN)
Alphabet Inc Class A cs (GOOGL)
Facebook Inc cl a (META)
Tesla Motors (TSLA)
Alphabet Opt Put Option (GOOG)
Visa Opt Put Option (V)
Broadcom Opt Call Option (AVGO)
Berkshire Hathaway (BRK.B)
JPMORGAN CHASE &amp Opt Put Option (JPM)

View all positions for Barclays

Top funds holding Kyverna Therapeutics

Vida Ventures Advisors
Northpond Ventures
Bain Capital Life Sciences Investors
Deerfield Management Company
Jennison Associates
T. Rowe Price Associates
Insight Holdings
Commodore Capital
Jpmorgan Chase & Co
BlackRock
Millennium Management
Henderson Group
Adage Capital Partners GP
Citadel Advisors
Logos Global Management

View all funds holding Kyverna Therapeutics